6m8p

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 6m8p is ON HOLD until Paper Publication
+
==Human ERAP1 bound to phosphinic pseudotripeptide inhibitor DG013==
-
 
+
<StructureSection load='6m8p' size='340' side='right'caption='[[6m8p]], [[Resolution|resolution]] 3.31&Aring;' scene=''>
-
Authors: Maben, Z., Stern, L.J.
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[6m8p]] is a 22 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6M8P OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6M8P FirstGlance]. <br>
-
Description: Human ERAP1 bound to phosphinic pseudotripeptide inhibitor DG013
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=P52:NALPHA-[(2S)-2-{[[(1R)-1-AMINO-3-PHENYLPROPYL](HYDROXY)PHOSPHORYL]METHYL}-4-METHYLPENTANOYL]-L-TRYPTOPHANAMIDE'>P52</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
-
[[Category: Unreleased Structures]]
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6m8p FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6m8p OCA], [http://pdbe.org/6m8p PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6m8p RCSB], [http://www.ebi.ac.uk/pdbsum/6m8p PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6m8p ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/ERAP1_HUMAN ERAP1_HUMAN]] Aminopeptidase that plays a central role in peptide trimming, a step required for the generation of most HLA class I-binding peptides. Peptide trimming is essential to customize longer precursor peptides to fit them to the correct length required for presentation on MHC class I molecules. Strongly prefers substrates 9-16 residues long. Rapidly degrades 13-mer to a 9-mer and then stops. Preferentially hydrolyzes the residue Leu and peptides with a hydrophobic C-terminus, while it has weak activity toward peptides with charged C-terminus. May play a role in the inactivation of peptide hormones. May be involved in the regulation of blood pressure through the inactivation of angiotensin II and/or the generation of bradykinin in the kidney.<ref>PMID:15908954</ref> <ref>PMID:16286653</ref> <ref>PMID:21478864</ref>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Large Structures]]
[[Category: Maben, Z]]
[[Category: Maben, Z]]
-
[[Category: Stern, L.J]]
+
[[Category: Stern, L J]]
 +
[[Category: Aminopeptidase]]
 +
[[Category: Antigen processing]]
 +
[[Category: Hydrolase]]
 +
[[Category: Hydrolase-inhibitor complex]]
 +
[[Category: Inhibitor]]

Revision as of 07:43, 18 December 2019

Human ERAP1 bound to phosphinic pseudotripeptide inhibitor DG013

PDB ID 6m8p

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools